Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
09/2012
09/04/2012CA2428462C Fluorescence-mediated molecular tomography
08/2012
08/30/2012WO2012113733A1 Nanoparticles as mrt contrast media for the diagnosis of hepatocellular carcinoma
08/30/2012WO2012068476A3 Poly(vinyl benzoate) nanoparticles for molecular delivery
08/30/2012US20120222139 Cancer Specific Mitotic Network
08/30/2012US20120220491 Retentate chromatography and protein chip arrays with applications in biology and medicine
08/30/2012US20120219508 Cellulose-based nanoparticles for drug delivery
08/30/2012US20120219507 Method of determining metabolic function
08/30/2012US20120219506 Catenae: Serosal Cancer Stem Cells
08/30/2012US20120219505 Peptide reagents and methods for detection of colon dysplasia
08/30/2012US20120219504 Complex of a protein comprising zinc oxide-binding peptides and zinc oxide nanoparticles, and use thereof
08/30/2012US20120219503 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
08/30/2012US20120219502 Methods and compositions for targeting gc1qr/p32
08/30/2012US20120219501 Biomarker en2 for gynaecological cancer
08/30/2012US20120219500 Diagnostic agent for infectious diseases
08/30/2012US20120219499 Compositions and methods for detecting plectin-1 as a biomarker for cancer
08/30/2012US20120219497 Random ethylene oxide and non-random alkylene oxide(s) polymers
08/30/2012US20120219496 Gadolinium-linked nanoclusters
08/30/2012US20120219495 Novel tetraaza macrocyclic compound, preparation method thereof and use thereof
08/30/2012DE102010042506B4 Verfahren für eine nuklearmedizinische Untersuchung eines Patienten mithilfe einer Magnetresonanzaufnahme und einer nuklearmedizinischen Aufnahme Method for a nuclear medicine examination of a patient using a magnetic resonance imaging and nuclear medicine intake
08/29/2012EP2491926A1 Treatment of protein degradation disorders
08/29/2012CN102652023A Labelled integrin binders
08/29/2012CN102650620A Preparation method, detection method and application of probe drug composition for determination of metabolic activity of cytochrome P450
08/29/2012CN102648701A Method for building spleen-deficiency chronic atrophic gastritis gastric precancerous lesions animal model
08/29/2012CN101977633B Process for preparing a pharmaceutical formulation of contrast agents
08/29/2012CN101780285B Thermal-enhanced polymer nano ultrasonic imaging micelle loaded with liquid fluorocarbon and preparation method thereof
08/28/2012US8252902 Complexing antigen, antibodies; immunoassay
08/28/2012US8252778 Highly fluorinated oils and surfactants and methods of making and using same
08/28/2012US8252267 DKKL-1 splice product modulators for cancer diagnosis and therapy
08/28/2012CA2447391C Substantially homogeneous bio-affecting material having a pre-determined ratio of transferrin to doxorubicin, its method of manufacture and its method of use
08/28/2012CA2402352C Fluorescent membrane intercalating probes and methods for their use
08/28/2012CA2284110C An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
08/23/2012WO2012112443A2 Anti-mucin antibodies for early detection and treatment of pancreatic cancer
08/23/2012WO2012112125A1 Use of magnetic vortex cores in magnetic resonance imaging and tumor treatment
08/23/2012WO2012110835A2 Prussian blue based nanoparticle as multimodal imaging contrast material
08/23/2012WO2012109755A1 Fatty ester-based particles and methods of preparation and use thereof
08/23/2012WO2012091518A3 Phospholipid nanoparticles for mr-induced high-intensity focused ultrasonic treatment and diagnosis, and method for producing same
08/23/2012WO2012075075A3 Methods and systems for spatially identifying abnormal cells
08/23/2012WO2012042446A3 Fibres and relative woven and non woven tissues for the topic treatment of sexual dysfunctions of the male genital apparatus
08/23/2012US20120216302 Methods and assays for treating subjects with shank3 deletion, mutation or reduced expression
08/23/2012US20120213831 Microspheres for active embolization
08/23/2012US20120213708 Hydrogel encapsulated cells and anti-inflammatory drugs
08/23/2012US20120213707 Riboflavin Based Aerosol and Use as Placebo in Trials
08/23/2012US20120213706 Reconstituted tumor microenvironment for anticancer drug development
08/23/2012US20120213705 ENGINEERED Fc REGIONS FOR SITE-SPECIFIC CONJUGATION
08/23/2012US20120213704 System and method for molecular in vivo imaging and theranostics
08/23/2012US20120213702 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13)
08/23/2012US20120213697 Versatile nanoparticulate biomaterial for controlled delivery and/or containment of therapeutic and diagnostic material
08/23/2012CA2827076A1 Anti-mucin antibodies for early detection and treatment of pancreatic cancer
08/22/2012EP2488211A1 Composition and method for medical imaging of body cavities
08/22/2012EP2488206A1 Porphyrin nanovesicles
08/22/2012EP2488197A1 Th1/th2 polarizing vaccines
08/22/2012EP2488172A2 Dendrimer compositions and methods of synthesis
08/22/2012EP2488164A2 Release of agents from cells
08/22/2012EP1615559B1 Method to determine the spatial distribution of magnetic particles and magnetic particle administering compositions
08/22/2012CN1997741B Novel mite allergen
08/22/2012CN102648005A Carrier
08/22/2012CN102643225A Ionic liquid, nano fluorescent ellipsoid and preparation method thereof
08/22/2012CN102641510A Preparation method of rat model for hypertension liver-yang hyperactivity
08/22/2012CN101940791B Dually-targeted pH-sensitive antineoplastic drug carrier material as well as preparation and application thereof
08/22/2012CN101637145B Biotransformation high GTF activity milk and manufacturing method thereof
08/22/2012CN101506179B Method of dynamic nuclear polarisation (DNP) and compounds and compositions for use in the method
08/22/2012CN101027310B Radicals and their use as paramagnetic agents in a dynamic nuclear polarisation process
08/21/2012US8246934 Respiratory dispersion for metered dose inhalers comprising perforated microstructures
08/21/2012US8246931 Development of a quail embryo model for the detection of botulinum toxin
08/21/2012US8246930 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
08/16/2012WO2012108856A1 Nanoparticulate manganese mri contrast agents
08/16/2012WO2012108648A2 Method of preparing iron oxide nanoparticles coated with hydrophilic material, and magnetic resonance imaging contrast agent using the same
08/16/2012WO2012107760A2 Layered bodies, compositions containing them and processes for producing them
08/16/2012WO2012107725A1 Materials and methods relating to cardiovascular imaging
08/16/2012WO2012107579A1 Hydrophobic modified peptides and their use for liver specific targeting
08/16/2012WO2012107577A1 Hydrophobic modified peptides for liver specific diagnosis
08/16/2012WO2012081893A3 Novel 3-indolinone derivative and composition having same
08/16/2012WO2012065045A3 Development and screening of contrast agents for in vivo imagining of parkinson's disease
08/16/2012US20120209116 Systems and Methods for Ultrasound Imaging and Insonation of Microbubbles
08/16/2012US20120207684 Composition and methods for imaging cells
08/16/2012US20120207683 Evaluation probe for central nervous system permeability, evaluation method for central nervous system permeability, and screening method using an evaluation probe for central nervous system permeability
08/16/2012US20120207682 Methods of treating macular edema using antiedema therapeutics
08/16/2012US20120207681 Chemical compositions to detect and treat amyloid in a patients brain and retina
08/16/2012US20120207680 Methods of Identifying Candidate Compounds of the Human G Protein-Coupled Receptor, GPR50, as Modulators of Body Mass or Adiposity
08/16/2012US20120207673 Modified Variable Domain Molecules And Methods For Producing And Using Same
08/15/2012EP2486944A1 Magnetic nanoparticles
08/15/2012EP2486849A2 Assessment of blood-brain barrier disruption
08/15/2012EP2486060A1 Siglec 15 antibodies in treating bone loss-related disease
08/15/2012EP2485768A1 Methods and compositions related to clot-binding lipid compounds
08/15/2012EP1976850B1 Novel lanthanide ligands and complexes, and use thereof as contrast agents
08/15/2012EP1901782B1 Method for dissolution of gases with short-lived physical properties in a liquid
08/15/2012EP1819374B1 Contrast agent coated medical device
08/15/2012CN1748791B Haemorrhagic E, coli 0157:H7 vaccine for human and livestock prevention and preparing method
08/15/2012CN102639153A Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents
08/15/2012CN102639152A Manganese chelates and their use as contrast agents in magnetic resonance imaging (MRI)
08/15/2012CN102633304A Bismuth sulfide nanorod with CT (computed tomography) angiography function, nano-composite material and preparation thereof
08/15/2012CN102631689A Magnetic resonance imaging contrast agent for diagnosis and treatment and preparation method thereof
08/15/2012CN102631688A Chinese medicinal preparation placebo for treating gonarthromeningitis and preparation method thereof
08/15/2012CN102000350B Folic acid receptor targeting type nano gold particles and preparation method thereof
08/15/2012CN101513542B Method for preparing iodic liquid embolic agent capable of self-developing for long-time
08/15/2012CN101497656B Polypeptide with high combination activity with integrin alpha v beta 3 and use thereof
08/14/2012US8241842 Methods and devices for measuring diffusion by magnetic resonance imaging
08/14/2012US8241608 Treating allergy with detoxified E. coli heat-labile enterotoxin
08/14/2012US8241607 Use of fructose-based compounds for the diagnosis of cancer
08/14/2012CA2373274C Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 354